Xu Xiao, Xu Huajuan, Li Ming, Yan Shuying, Chen Huilin
Intensive Care Unit (ICU), Shanghai Construction Group Hospital, No. 666, North Zhongshan Road Number One, Hongkou District, Shanghai, 200083, China.
Diabetol Metab Syndr. 2024 Aug 8;16(1):191. doi: 10.1186/s13098-024-01420-x.
This study aims to evaluate the association of metabolic syndrome (MetS) with the risk of all-cause mortality in elderly patients with acute respiratory distress syndrome (ARDS).
Elderly ARDS patients (≥ 65 years) enrolled from our hospital between January 2018 and July 2023 were divided into the MetS group or the non-MetS group. The outcomes were 28-day and 90-day all-cause mortality rates in the total population and two subgroups stratified by age (65-75 years and ≥ 75 years). Multivariate Cox regression was employed to assess the association of MetS with all-cause mortality, after controlling for potential cofounding factors.
A total of 946 patients were divided into the MetS group (n = 410) or the non-MetS group (n = 536). The 28-day and 90-day all-cause mortality rates were significantly higher for MetS group compared to non-MetS group in the total population and two subgroups (all P < 0.01). Multivariate Cox regression indicated that MetS was significantly associated with a higher risk of 90-day all-cause mortality in the total population (HR = 1.62, 95% CI: 1.22-2.15; P < 0.01), and subgroups of patients aged 65-75 years (HR = 1.52, 95% CI: 1.04-2.21; P = 0.03) and ≥ 75 years (HR = 1.90, 95% CI: 1.23-2.94; P < 0.01). Moreover, with each MetS criterion added from 0 to 1 to 2, 3, and 4 of 4 criteria, both 28-day and 90-day all-cause mortality rates significantly increased (both P < 0.01).
MetS was associated with higher risks of 28-day and 90-day all-cause mortality in elderly patients with ARDS.
本研究旨在评估代谢综合征(MetS)与老年急性呼吸窘迫综合征(ARDS)患者全因死亡风险之间的关联。
选取2018年1月至2023年7月期间我院收治的老年ARDS患者(≥65岁),分为MetS组和非MetS组。观察指标为总体人群以及按年龄分层的两个亚组(65 - 75岁和≥75岁)的28天和90天全因死亡率。在控制潜在混杂因素后,采用多因素Cox回归分析评估MetS与全因死亡率的关联。
共946例患者分为MetS组(n = 410)和非MetS组(n = 536)。总体人群及两个亚组中,MetS组的28天和90天全因死亡率均显著高于非MetS组(均P < 0.01)。多因素Cox回归分析表明,MetS与总体人群90天全因死亡风险显著相关(HR = 1.62,95%CI:1.22 - 2.15;P < 0.01),在65 - 75岁亚组(HR = 1.52,95%CI:1.04 - 2.21;P = 0.03)和≥75岁亚组(HR = 1.90,95%CI:1.23 - 2.94;P < 0.01)中也是如此。此外,随着MetS标准从4项标准中的0项增加到1项、2项、3项和4项,28天和90天全因死亡率均显著升高(均P < 0.01)。
MetS与老年ARDS患者28天和90天全因死亡风险较高相关。